Anca-associated Vasculitis
📧 Sign up to get email alerts when something new happens for Anca-associated Vasculitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
Early-phase clinical study of a targeted CD19/BCMA CAR-T therapy for autoimmune diseases is recruiting, including systemic lupus erythematos…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis [Phase 4]
A Phase 4 clinical trial is evaluating Avacopan in participants with ANCA-associated vasculitis and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Avacopan Added to Standard-of-care Therapy in ANCA-associated Vasculitis With Severe Kidney Involvement [Phase 3]
A Phase 3 clinical trial is evaluating adding avacopan to standard-of-care therapy for ANCA-associated vasculitis with severe kidney involve…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy [EARLY_Phase 1]
An early-phase 1 clinical trial of IMPT-514 in systemic lupus erythematosus, ANCA-associated vasculitis, and idiopathic inflammatory myopath…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating QT-019C, a CD19 and BCMA-targeted CAR T-cell therapy, for relapse/refractory autoimmune diseases; recrui…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating the safety and efficacy of a targeted BCMA in vivo lentiviral vector injection for recurrent or r…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases [NA]
This clinical trial is recruiting to evaluate anti-CD19 IL-10/IL-15 CAR-NK cells for refractory/relapsed autoimmune diseases. Conditions inc…
-
CLINICAL_TRIALS other · 2025-12-24Clinical Trial Update: Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating BCT301 cell injection therapy for refractory autoimmune diseases, including systemic lupus erythe…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases [NA]
A clinical trial update evaluating CD19 UCAR-T cell therapy in autoimmune diseases; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
This clinical trial aims to characterize autoreactive B lymphocytes in autoimmune diseases and immune deficiencies. The study status is not …
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator
A completed clinical trial comparing rituximab biosimilars to the originator in ANCA-associated vasculitis, including granulomatosis with po…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis [NA]
This entry reports the termination of a clinical trial evaluating maintenance therapy tailored to CD5+ regulatory B cell recovery in ANCA-as…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy [Phase 2]
A Phase 2 trial update on innovative pneumococcal vaccine strategies for patients with ANCA-associated vasculitis receiving rituximab therap…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab [Phase 3]
A Phase 3 trial comparing long-term versus conventional rituximab maintenance in ANCA-associated vasculitis has completed, with results repo…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides [Phase 3]
A Phase 3 multicenter, randomized, double-blind trial evaluated whether rosuvastatin affects subclinical markers of atherosclerosis in patie…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: (68)Ga-FAPI PET/CT in Patients With ANCA-associated Vasculitis
A clinical trial evaluating the use of Gallium-68 labeled FAPI PET/CT imaging for ANCA-associated vasculitis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases [Phase 1, Phase 2]
An open-label Phase 1/2 study evaluating povetacicept in autoantibody-associated glomerular diseases is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. [EARLY_Phase 1]
Phase 1 study evaluating anti-CD19/BCMA universal CAR-T cell therapy RD06-05 in autoimmune diseases; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update assessing a dual CD19/BCMA-targeted CAR T-cell therapy for relapse/refractory autoimmune diseases, currently r…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
This clinical trial update describes ongoing research in safety and efficacy assessment for rheumatologic diseases and related conditions, w…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC) [Phase 2]
This update describes a Phase 2 clinical trial (SPARVASC) examining ETA receptor antagonism and AT1 receptor antagonism in ANCA-associated v…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases [Phase 1, Phase 2]
This clinical trial update describes a phase 1/2 study evaluating universal CD19-targeting CAR-γδT cells for refractory autoimmune diseases,…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis [Phase 1, Phase 2]
Phase 1/2 trials evaluating substitution of glucocorticoid for BDB-001 in ANCA-associated vasculitis have completed, with reported efficacy …
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Clinical trial update describing the EACVI study on multimodality cardiovascular imaging for inflammatory cardiovascular diseases, with myoc…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating YTS109 cell therapy for relapsed/refractory autoimmune diseases is currently recruiting. The study cover…